Enzolytics Inc (ENZC)

[southswell7]

Nice!! 4 Patents between the 2 Companies and I just got that feeling, MORE Monster News is not far off, especially after reading this:

We were recently (within the last 3 weeks) asked by Bravo Healthcare, Ltd. (https://bravopharma.com) to partner with them in an application to CEPI (https://cepi.net) to produce a vaccine against the Coronavirus. As you know, this virus has caused a critical worldwide health crisis facing all countries. Because of the urgency of the medical and related financial costs posed by this virus, the call by CEPI for applications for therapies to address the situation was open for only a very short period. Our application was filed yesterday February 13, 2020.
• Those entities joining in our application include:
o Bravo Healthcare Ltd., bravopharma.com
o Rihim Pharma, rihimpharma.com
o JSS Medical Research, jssresearch.com
o IcosagenLtd, icosagen.com
o University of Tartu, ut.ee
o University of California, universityofcalifornia.edu
• CEPI (pronounced “seppy”) has as its objective the acceleration of development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks. It is an organization founded in Davos, Switzerland by the governments of Norway and India, the Gates Foundation, the Wellcome Trust and the World Economic Forum. It has secured $760 Million toward its $1 Billion Funding target, with multi year funding from Norway, UK, Germany, japan, Canada, Ethiopia, Australia and the Gates Foundation and Wellcome Trust. It also has received single-year installments from Belgium, and the European Commission. Our partner in this application, Bravo Pharma is headquartered in Europe and Estonia.
• Why were we contacted by Bravo to partner in this program? The Coronavirus has structure corresponding to that of the HIV virus. Because our monoclonal antibody has been shown to neutralize the HIV virus in 5 international lab testing programs, and because we know the structure to which the antibody binds resulting in neutralization, this knowledge provides insight necessary to identifying the structure (amino acid sequence) we consider the corresponding “Achilles Heel” of the Coronavirus. From this knowledge, a phage display vaccine is proposed to be produced and tested against the virus. We have a working relationship with the California Animal Trials Center at the University of California for testing the proposed vaccine or, due to the urgency of the situation, direct clinical trials could be approved. Production and delivery of a successful vaccine would be carried out by the other partners to the application.
We are working diligently to make progress, and we extend our sincere appreciation for your support.
Best regards,
Charles Cotropia
CEO
BioClonetics Immunotherapeutics, Inc.


Night all, things to get done